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Background: It is increasingly being realized that failure of pancreatic beta cells to secrete enough insulin to
adequately compensate for obesity and insulin resistance is the primary defects of type 2 diabetes mellitus (T2DM).
Pancreatic beta cells possess a highly developed and active endoplasmic reticulum (ER), reflecting their role in
folding, export and processing of newly synthesized insulin. ER stress-induced pancreatic beta-cell failure is a novel
event in the pathogenesis of T2DM. Some studies with antioxidants indicated a beneficial impact on ER stress. Our
previous study found that strong antioxidants, grape seed proanthocyanidins (GSPs), ameliorated ER stress to
protect skeletal muscle from cell death in type 2 diabetic rats. The present study continued to investigate the effect
of GSPs on beta-cell failure and ER stress in diabetic pancreas.
Methods: Male Sprague–Dawley rats made type 2 diabetic with 2 injections of 25 mg/kg streptozotocin and
8 weeks of the high-carbohydrate/high-fat diet were fed a basal diet with or without GSPs administration for
16 weeks. Oral glucose tolerance, plasma glucose, serum insulin and the score of beta-cell function were measured.
Morphological observation was performed by light and electron microscopic analyses. Islet cell apoptosis was
determined by terminal deoxynucleotidyl transferase-mediated dUTP biotin nick end labeling staining. Additionally,
the level of insulin and the expression of ER stress markers in pancreatic islets were also studied using
immunohistochemical staining.
Results: After 16 weeks treatment, the score of beta-cell function and the abnormal oral glucose tolerance of
diabetic rats were partially reversed by GSPs treatment. The efficacious effect of GSPs was also manifested in the
amelioration of pancreatic damage and ER dilatation by microscopic analyses. Moreover, GSPs treatment increased
normal insulin content and decreased the number of apoptotic cells in diabetic islets. Importantly, GSPs treatment
partially alleviated ER stress by decreasing some ER stress markers.
Conclusion: These findings suggest that GSPs might have auxiliary therapeutic potential for pancreatic beta-cell
dysfunction and death in T2DM.
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Modern lifestyles, with increased caloric consumption and
reduced physical activity, have dramatically increased the
rates of obesity-associated disease conditions, including
type 2 diabetes mellitus (T2DM). It was estimated that ap-
proximately 366 million people (aged 20–79) worldwide
had diabetes in the year 2011; with T2DM accounting for
90-95% of all diagnosed cases [1]. Numerous studies show
that insulin resistance, often associated with obesity and
physical inactivity, precedes the development of hypergly-
cemia in subjects that eventually develop T2DM [2,3].
However, it is increasingly being realized that failure of
pancreatic beta cells to secrete enough insulin to ad-
equately compensate for obesity and insulin resistance is
the primary defects of T2DM [4,5]. Therefore, effective
therapeutic strategies to prevent or delay the development
of pancreatic beta-cell dysfunction and death may be de-
sirable for the control of this disorder.
Pancreatic beta cells possess a highly developed and
active endoplasmic reticulum (ER), reflecting their role
in folding, export and processing of newly synthesized
insulin [6]. Certain conditions, such as high lipid load,
hyperglycemia, oxidative stress, excessive Ca2+ release
from ER stores, or misfolded mutant insulin proteins,
will disrupt ER homeostasis, resulting in an adaptive un-
folded protein response (UPR), which aims to restore ER
folding capacity and mitigate stress [7]. One of the most
described mechanisms of UPR activation is the competi-
tion model, in which the ER chaperone protein glucose
regulated protein 78 (GRP78) plays an essential role in
the activation of different ER stress transducers [7].
However, under conditions of severe and prolonged ER
stress, the UPR is unable to restore normal cellular func-
tion. Subsequently, cell death is triggered. This effect is
mediated in part by increased expression of the tran-
scription factor C/EBP homologous protein (CHOP) and
activities of Jun N terminal kinase (JNK) and Caspase-12
[8]. Accumulating evidence based on in vivo and in vitro
studies also has demonstrated that ER stress is a novel
causative factor of pancreatic beta-cell dysfunction and
death in the pathogenesis of T2DM [9-11].
Some studies showed that antioxidants (e.g. the heavy
metal scavenger antioxidant metallothionein, and antioxi-
dant N-acetylcysteine) had a beneficial impact on ER stress
[12,13], indicating that the use of antioxidants offer the
possibility for improvement of ER stress and beta-cell dys-
function in T2DM. In recent years, natural dietary compo-
nents are being pursued as alternatives to pharmaceutical
interventions. Grape seed proanthocyanidins (GSPs), which
are derived from grape seeds, refer to a group of pro-
anthocyanidins mostly containing dimers, trimers and
other oligomers of catechin and epicatechin and their gallic
acid esters. Interestingly, the in vitro antioxidative activities
of GSPs were found to be much stronger than that ofvitamin C and vitamin E, singly and in combination [14,15].
Moreover, previous animal studies based on type 1 diabetes
mellitus reported that GSPs exerted anti-hyperglycemic
property [16,17]. Among these few studies, GSPs was
reported to ameliorate pancreatic damage by alleviation
of oxidative stress [16]. Our previous study found that
GSPs ameliorated ER stress to protect skeletal muscle
from cell death in a type 2 diabetic model [18]. How-
ever, the protective effect of GSPs on pancreatic damage
of T2DM and the relevant mechanisms of ER stress also
need further elucidation.
In the present study, we used low dose streptozotocin
(STZ) and a high-carbohydrate/high-fat diet induced type
2 diabetic rats to investigate whether long-term GSPs ad-
ministration would result in the improvement of pancre-
atic beta-cell dysfunction and death and to check whether
this protective effect of GSPs would be, in part, due to
downregulation of ER stress.
Materials and methods
Animals
The Institutional Animal Care and Use Committee of
Peking University approved the protocols before starting.
80 male Sprague–Dawley rats (180–200 g) were purchased
from Animal Service of Health Science Center (Peking
University) and housed 2 per cage in this center with 12 h
light-12 h dark cycles (light time began at 7:30 AM) under
controlled humidity (60 ± 5%) and temperature (25 ± 1°C).
All animal care and experimental procedures were in ac-
cordance with the Guide for the Care and Use of Labora-
tory Animals (NIH publication No. 85–23, 1985).
Reagents
Basal diet (AIN-93G diet) and the high-carbohydrate/high-
fat diet (66% basal diet, 15% lard, 10% plantation white
sugar, 6% casein and 3% yolk powder) were produced by
Beijing Keao Xieli Co. Ltd. (Beijing, China). GSPs (Lot No:
1003007–24) were purchased from Jianfeng Natural Prod-
ucts Co. Ltd. (Tianjing, China). The proanthocyanidin
content was 96.64% while analyzed using HPLC with
gas chromatography–mass spectrometry detection. They
contained 6.1% catechin, 6.78% epicatechin, 55.59% di-
meric forms, 11.91% trimeric forms, 6.55% tetrameric
forms and small amounts of other polymeric forms. STZ
and proteinase K were from Sigma-Aldrich (St. Louis,
Missouri, USA). In situ cell death detection, [terminal
deoxynucleotidyl transferase-mediated dUTP biotin nick
end labeling (TUNEL) assay] kit was purchased from
Roche Molecular Biochemicals (Mannheim, Germany).
The insulin antibody was from Cell Signaling Technology
(Danvers, Massachusetts, USA). The antibodies for GRP
78, CHOP, phosphorylated JNK and Caspase-12 were
obtained from Santa Cruz Biotechnology (California,
USA). 4’,6-diamidino-2-phenylindole (DAPI), fluorescein
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immunohistochemistry kit were from Beijing Zhongshan
Golden Bridge Biotechnology Co. Ltd. (Beijing, China). All
other common chemicals were of analytical reagent grade.Experimental protocol
Rats were acclimatized to new environment for 1 week,
and were then randomly divided into 3 groups. Group 1
(n = 12, normal control) and group 2 [n = 12, 250 mg/kg
body weight (BW) GSPs control] were both fed the basal
diet. Rats in group 3 (n = 56) were induced by 2 injections
of 25 mg/kg BW STZ and 8 weeks of the high-
carbohydrate/high-fat diet as described previously [18].
Rats with plasma glucose levels between 250 mg/dl and
400 mg/dl at 2 weeks post STZ injection were considered
suitable and only uniformly diabetic rats were used in the
next experiments. The diabetic rats were randomly di-
vided into 4 groups (n = 12 each), including diabetic con-
trol group and 3 GSPs intervention groups (125, 250, and
500 mg/kg BW respectively). Then, the normal and dia-
betic control groups were given water, while the other four
groups were administered GSPs by stomach tube. During
the following 16 weeks, all groups were allowed free access
to the basal diet (Figure 1).Oral glucose tolerance test (OGTT)
The OGTT procedure was performed at the end of 1 and
16 week after induction of diabetes. Rats were food re-
stricted and were given only water to drink for 6 h. Blood
samples for plasma glucose were then collected from
snipped tails by tail milking at 0, 30, 60, and 120 min after
administration of D-glucose (20% solution; 2 g/kg BW) by
stomach tube.Figure 1 Schematic representation of the experimental procedures. T
diabetic with low dose streptozotocin and a high-carbohydrate/high-fat di
tolerance test.Measurement of serum parameters
Sixteen weeks after induction of diabetes, plasma glucose
and serum insulin were determined as described previously
[18]. Homoeostasis model assessment (HOMA) of beta-cell
function (HOMA-B) was calculated by the HOMA method
using the following equations [19]: HOMA-B = (20 × fasting
insulin (μIU/ml)) / (fasting glucose (mmol/l) – 3.5).
Treatment of pancreas tissue
Following blood collection, rats were sacrificed by cer-
vical dislocation. Pancreas were carefully excised,
cleared of fat, and rinsed in ice-cold saline. After remov-
ing the excess water on the surface with filter paper,
pancreas was weighed and pancreas/BW ratio was eval-
uated. Then part of pancreas was fixed in 4% parafor-
maldehyde for hematoxylin/eosin (HE), TUNEL and
immunohistochemical staining. In addition, a small por-
tion of the same pancreas region from each group was
immersed overnight in 2.5% glutaraldehyde (pH 7.4) in
0.1 mol/l phosphate buffered saline (PBS) at 4°C.
Light and electron microscopy
For light microscopy, the fixed tissue samples were
dehydrated through a graded ethanol series, embedded in
paraffin and cut into 7 μm-thick sections with HE stain
using a routine protocol. The stained sections were then
observed from× 100 to × 400 magnifications. For electron
microscopy, pancreas were removed from 2.5% glutaralde-
hyde and adequately washed in 0.1 mol/l PBS. Blocks (ap-
proximately 1 mm wide, 2 mm long and 1 mm thick) were
post-fixed in 1% osmium tetroxide, dehydrated through a
graded series of ethanol, and embedded in Epon 812. After
being stained with toluidine blue, suitable areas of sections
for ultrastructural study were chosen. Then microsections
were cut and mounted on a copper grid. All the sectionshe present study was performed in Sprague–Dawley rats made
et. GSPs: grape seed proanthocyanidins; OGTT: oral glucose
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citrate. The ultrastructure of pancreatic beta cells was
checked from × 4000 to × 12000 magnification using
transmission electron microscope. Two independent
pathologists performed the morphological observation
in a blinded fashion.
Detection of apoptosis
Paraffin sections were deparaffinized in xylene, down-
graded in alcohol grades (100, 95, 85 and 70%), washed
with PBS and treated with proteinase K (2 μg/ml) for di-
gestion. Islet cell apoptosis was determined by TUNEL
staining according to the manufacturer’s protocols. The
insulin antibody and FITC-labeled secondary antibody
were used to probe insulin. DAPI was used to visualize
nuclei. The slides were then visualized by fluorescence
microscope. Apoptotic cells exhibited strong nuclear
red fluorescence. Frequency of pancreatic islet cell
apoptosis was expressed as events per islet.
Immunohistochemistry
Paraffin sections were deparaffinized, hydrated, and
steamed in citrate buffer for 5 min for antigen retrieval.
Endogenous peroxidase activity was inhibited using 3%
hydrogen peroxide in methanol for 10 min. The sections
were then incubated following the instructions in the
commercial manual. Briefly, sections were blocked with
protein-blocking agent followed by incubation with pri-
mary antibodies (1:200) at 4°C overnight. Then they were
incubated in turn with biotinylated secondary antibodies,
with streptavidin peroxidase reagent, and with 3, 3-
diaminobenzidine for color development. Counterstaining
was carried out with hematoxylin. Each step was separated
by careful washings in PBS buffer. Slides were then ana-
lyzed from × 100 to × 400 magnifications by two blinded
pathologists under a light microscope. Image-Pro Plus 6.0
software was used to assess quantitative values.
Statistical analysis
Statistical analysis was performed using SPSS (version
13.0). All data were compared by one-way ANOVA ana-
lysis, followed by LSD (equal variances assumed) or
Dunnett’s T3 (equal variances not assumed) for post-hoc
test between multiple groups. Values of P < 0.05 were
considered significant.
Results
Effect of GSPs on BW and food consumption
The number remaining alive at the end of the study in the
6 groups was 12, 12, 12, 11, 12 and 12 respectively of nor-
mal control, GSPs control, diabetic control and 3 GSPs
intervention groups. As shown in Table 1, there were no
differences in BW and food consumption between normal
and GSPs control groups. As expected, the level of BWwas lower in diabetic control rats than that in normal con-
trol ones at the end of the study (P < 0.001). Additionally,
food consumption was greater in diabetic rats than that in
normal control rats throughout the study period (P < 0.05
for each). However, the GSPs treatment slightly increased
BW and decreased food consumption in a dose-dependent
manner.
Effect of GSPs on glucose and insulin metabolism
parameters
As described previously [16], diabetic rats showed signifi-
cant increases in plasma glucose and serum insulin when
compared with normal control rats (P < 0.05 for each). The
500 mg/kg BW GSPs, however, showed a significant im-
provement in plasma glucose level (P = 0.024) (data not
shown). Additionally, HOMA-B, which is used to quantify
beta-cell function, was higher in GSPs control groups than
that in normal control rats (P < 0.05). As expected, STZ-
and high-carbohydrate/high-fat diet treatment significantly
decreased the score of HOMA-B (P < 0.001), whereas the
500 mg/kg BW GSPs treatment slightly increased this par-
ameter (P < 0.05) (Table 1).
Effect of GSPs on oral glucose tolerance
The two OGTTs were performed at the end of 1 and
16 week after induction of diabetes. The initial OGTT
(Figure 2A) showed significant increases in basal, 30-, 60-,
and 120-min plasma glucose values in diabetic groups
when compared with normal control group (P < 0.05
for each). Data from the second OGTT were similar
(Figure 2B), with significantly increased plasma glucose
values observed at all time points in diabetic groups (P <
0.05 for each). Interestingly, 30-min plasma glucose values
were significantly lowered in both 250 and 500 mg/kg BW
GSPs-treated diabetic groups during the second OGTT
when compared with diabetic control group (P = 0.022 and
P = 0.016, respectively).
Effect of GSPs on pancreas weight and pancreas/BW ratio
As shown in Table 1, there were no significant differences
in pancreas weight and pancreas/BW ratio between nor-
mal and GSPs control groups. Pancreas weight of diabetic
rats was significantly decreased when comparing with that
of normal control ones (P = 0.009). However, pancreas/
BW ratio of diabetic rats was greater than that of normal
control rats (P < 0.05). This increase was almost totally
explained by the decrease in BW. Regretfully, administra-
tion of GSPs had no obvious effects on pancreas weight
and pancreas/BW ratio of diabetic rats.
Effect of GSPs on pancreatic histopathology
Histopathological observations were shown in Figure 3.
Pancreatic histology of normal control rats was normal
throughout the whole study. The appearance of GSPs
Table 1 Body weight (BW), food intake, homoeostasis model assessment of beta-cell function (HOMA-B), pancreas/BW
ratio and the frequency of apoptotic islet cells in normal and diabetic rats after 16 weeks of GSPs treatment
Parameter Normal rats Diabetic rats
Vehicle GSPs (mg/kg BW) Vehicle GSPs (mg/kg BW)
250 125 250 500
Initial BW (g) 459.85 ± 6.93 466.73 ± 7.17 441. 06 ± 11.05 453.72 ± 13.99 437.92 ± 9.71 454.30 ± 10.34
Final BW (g) 584.29 ± 13.44 # 544.63 ± 14.88 # 417.88 ± 9.75 * 436.38 ± 9.00 * 447.57 ± 12.74 * 446.63 ± 10.57 *
Initial food intake (g/day) 19.43 ± 0.83 # 17.77 ± 1.32 # 30.30 ± 1.03 * 29.93 ± 1.09 * 29.15 ± 1.69 * 29.81 ± 0.44 *
Final food intake (g/day) 23.88 ± 1.87 # 20.31 ± 0.73 # 38.83 ± 1.64 * 37.31 ± 1.65 * 34.30 ± 1.46 * 30.74 ± 0.23 *
HOMA-B 176.34 ± 7.88 # 228.63 ± 10.63 * # 35.61 ± 1.62 * 47.77 ± 3.06 * 46.76 ± 1.54 * 51.51 ± 2.91 * #
Pancreas weight (g) 1.33 ± 0.03 # 1.31 ± 0.04 # 1.16 ± 0.04 * 1.19 ± 0.07 * 1.20 ± 0.04 1.22 ± 0.04
Pancreas/BW ratio (‰) 2.27 ± 0.09 # 2.40 ± 0.10 # 2.84 ± 0.15 * 2.73 ± 0.10 * 2.69 ± 0.11 * 2.74 ± 0.09 *
Apoptotic cells/islet 1.75 ± 0.37 # 1.58 ± 0.31 # 8.92 ± 0.87 * 7.75 ± 0.77 * 7.42 ± 0.79 * 5.36 ± 0.54 * #
BW and food intake were measured once a week after induction of diabetes. The frequency of apoptotic islet cells was evaluated by averaging the number of
TUNEL-positive cells in approximately 50 islets from each group. The other data were means ± SEM of 10 rats of each group.
* Designated statistically significant difference from vehicle-treated normal rats, P < 0.05, # designated statistically significant difference from vehicle-treated
diabetic rats, P < 0.05.
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of normal control ones. On the contrary, pancreas
showed evidence of severe damage characterized by re-
duced pancreatic islet area in diabetic control rats. Al-
though 125 mg/kg BW GSPs had no notable effect on
the level of damage, the atrophied pancreatic islets
were ameliorated in 250 and 500 mg/kg BW GSPs-
treated diabetic rats.
Electron microscopic analysis of pancreatic beta cells
Pancreatic beta cells store insulin in secretory granules that
undergo exocytosis upon glucose stimulation. As depicted
in Figure 4, beta cells of normal rats contained secretory
granules in the cytoplasm, with moderate homogenous, or
slightly heterogenous electron density; meanwhile, the nu-
cleus, mitochondria and ER were normal in beta cells of
these rats. However, secretory granules of beta cells ofFigure 2 Effect of GSPs on oral glucose tolerance in normal and diab
test procedure in normal and diabetic rats was determined at the end of 1
for each group of 6 animals. Group a = vehicle-treated normal rats; group b
diabetic rats; group d = GSPs (125 mg/kg BW)-treated diabetic rats; group e
(500 mg/kg BW)-treated diabetic rats. * P < 0.05 versus data from vehicle-tr
diabetic rats at the indicated times, respectively.diabetic rats were significantly diluted when compared
with that of normal rats (P < 0.001), suggesting immature
granules were increased. In addition, pancreatic beta cells
of diabetic rats showed pathological alterations, including
nuclear condensation, mitochondrial vacuolization, and
swelling and dilatation of ER. 250 and 500 mg/kg BW
GSPs treatments had obvious beneficial effects on the di-
luted secretory granules (P = 0.03 and P = 0.003, respect-
ively). The protective effect of GSPs (especially at the dose
of 500 mg/kg BW) on diabetic rats was also evident with
moderate increases in normal mitochondria, moderate
dilatation of ER and the apparently normal architecture
of nucleus.
Effect of GSPs on islet cell apoptosis
Islet cells undergoing apoptosis were determined by im-
munostaining for TUNEL assay (Figure 5 and Table 1).etic rats. Plasma glucose response during the oral glucose tolerance
(A) and 16 (B) week after induction of diabetes. Values were obtained
= GSPs (250 mg/kg BW)-treated normal rats; group c = vehicle-treated
= GSPs (250 mg/kg BW)-treated diabetic rats; and group f = GSPs
eated normal rats, and # P < 0.05 versus data from vehicle-treated
Figure 3 Effect of GSPs on pancreatic histopathology in normal and diabetic rats. See Figure 2 for groups and treatment. Scale bar = 50 μm.
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GSPs control islets. However, STZ- and high-carbohydrate/
high-fat diet treatment significantly increased the number
of TUNEL-positive staining cells compared with normal
control ones (P < 0.001). Interestingly, administration of
GSPs to diabetic rats reduced TUNEL staining within islet
cells in a dose-dependent manner, and 500 mg/kg BW
GSPs significantly decreased cell apoptosis when compared
with diabetic control rats (P < 0.001).
Effect of GSPs on insulin expression in pancreatic islets
Figure 6 and Table 2 demonstrated the level of insulin in
pancreatic islets of each group. Healthy pancreatic islets in
normal groups exhibited diffused staining with brown or
yellow granules. In marked contrast, the insulin expression
in diabetic pancreas decreased significantly (P = 0.001)characterized by the depletion of brown or yellow granules.
Administration of 500 mg/kg BW GSPs to diabetic rats sig-
nificantly increased the level of insulin when compared with
diabetic control rats (P = 0.018). But 125 and 250 mg/kg
BW GSPs treatments had no beneficial effects on the
decreased insulin levels (data not shown).
Effect of GSPs on ER stress in pancreatic islets
We finally examined the progression of ER stress in pancre-
atic islets. As can be seen in Figure 6 and Table 2, GRP78,
CHOP, phosphorylated JNK and Caspase-12 were all
expressed at low levels in both vehicle-treated and GSPs-
treated normal rats. However, these ER stress markers were
all significantly elevated in pancreatic islets of diabetic ani-
mals compared with that in normal control ones (P < 0.05
for each). Interestingly, 500 mg/kg BW GSPs significantly
Figure 4 Electron microscopic studies on pancreatic beta cells of normal and diabetic rats. Ultrastructural organization of pancreatic beta
cells (A). Scale bar = 1 μm. ER: endoplasmic reticulum; MC: mitochondria; N: nucleus; SG: secretory granules. Mean density of SG was assessed by
Image-Pro Plus 6.0 software and calculated as means ± SEM of 20 determinations in each group (B). See Figure 2 for groups and treatment.
* P < 0.05 versus vehicle-treated normal rats, and # P < 0.05 versus vehicle-treated diabetic rats.
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inhibited the protein expressions of GRP78, CHOP and
Caspase-12. Nonetheless, 125 and 250 mg/kg GSPs treat-
ments did not significantly inhibit the elevated ER stress
markers (data not shown).
Discussion
It was suggested that extreme nutritional condition was a
good way to initiate insulin resistance (IR) [20,21]. At the
same time, multi-administration of low dose STZ induced agradual, autoimmune destruction of beta cells, which might
happen in decompensated phase of T2DM [22-24]. In the
preliminary experiment, we developed rat models by feed-
ing them with a high-carbohydrate/high-fat diet for 8 weeks
accompanying by low dose STZ (20, 25, 30 mg/kg BW)
twice injection. Based on our criteria for diabetes (fasting
glucose ≥ 250 mg/dl), the successful rate of 25 mg/kg BW
STZ group was significantly high and the rats presented a
typical characteristic of T2DM as hyperglycemia, IR, and
blood lipid disorder, but without decreased serum insulin
Figure 5 Effect of GSPs on islet cell apoptosis in normal and diabetic rats. The slides were visualized by fluorescence microscope. The insulin
antibody and fluorescein isothiocyanate (FITC)-labeled secondary antibody were used to probe insulin (green). 4’, 6-diamidino-2-phenylindole (DAPI) was
used to visualize nuclei (blue). Apoptotic cells exhibited strong nuclear red fluorescence using regional terminal deoxynucleotidyl transferase-mediated
dUTP biotin nick end labeling (TUNEL) staining. See Figure 2 for groups and treatment. Scale bar = 50 μm.
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Figure 6 Immunohistochemistry study on insulin and endoplasmic reticulum stress of islets in normal and diabetic rats. See Figure 2 for
groups and treatment. Scale bar = 50 μm. GRP78: 78-kDa glucose-regulated protein; CHOP: C/EBP homologous protein; Phospho-JNK:
phosphorylated Jun N terminal kinase.
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quent experiments. At the end of the study, diabetic rats
still showed symptoms of hyperglycemia, hyperinsulinemia,
IR and blood lipid disorder (more details were referred to
in our recent report [18]). Concomitantly, pancreatic
damage and dysfunction were also existed. Altogether, these
results indicated that this stable animal model in the
present study might be suitable to investigate the pathogen-
esis of pancreatic dysfunction and T2DM.So far, the effects of GSPs have been mainly based on
chemically induced type 1 diabetic animals. Among these
studies, the results that GSPs had no hypoglycemic effects
also existed [25,26]. These contradictory conclusions most
likely resulted from multiple factors, including animal spe-
cies, small sample size, plasma glucose detection methods,
changes in dosage and injection techniques of chemical
agents, and variation in GSPs dosage and duration. By con-
trast and in accordance with our data, the administration of
Table 2 Effects of GSPs on the expression of insulin and endoplasmic reticulum stress markers {78-kDa glucose-regulated
protein (GRP78), C/EBP homologous protein (CHOP), phosphorylated Jun N terminal kinase (Phosphor-JNK) and
Caspase-12} of pancreatic islets in normal and diabetic rats
Parameter (integrated optical density) Normal rats Diabetic rats
Vehicle GSPs (250 mg/kg BW) Vehicle GSPs (500 mg/kg BW)
Insulin expression 39674.25 ± 3027.60 # 38034.72 ± 2493.37 # 2337.21 ± 531.25 * 6942.99 ± 896.58 * #
GRP78 expression 1690.20 ± 491.01 # 1762.32 ± 468.30 # 15823.37 ± 2946.95 * 4180.61 ± 384.72 *
CHOP expression 2835.46 ± 711.55 # 2595.55 ± 539.14 # 5725.45 ± 1077.68 * 4642.29 ± 1048.88
Phospho-JNK expression 364.21 ± 109.88 # 395.41 ± 151.75 # 3280.48 ± 661.21 * 682.39 ± 250.81 #
Caspase-12 expression 480.29 ± 134.28 # 518.60 ± 169.85 # 5573.96 ± 1106.86 * 3768.57 ± 773.68
Data were means ± SEM of 50 pancreatic islets of each group.
* designated statistically significant difference from vehicle-treated normal rats, P < 0.05, # designated statistically significant difference from vehicle-treated
diabetic rats, P < 0.05.
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cacao liquor and cinnamon bark) were reported to have
hypoglycemic activities in type 2 diabetic animal models
[27-29]. Interestingly, the present study showed that GSPs
exerted ameliorative effects on hyperglycemia in type 2
diabetic animal models. The effects might be accomplished
in part by restoration of normal architecture and function
of beta cells, as an in vivo study based on type 1 diabetic
models showed [16].
The remained beta cells mass in diabetic rats places a
high demand on the ER for the synthesis of proinsulin.
Since proinsulin represents up to 20% of the total mRNA
and 30-50% of the total protein synthesis in beta cells [30],
misfolded mutant insulin proteins might be a potent cause
of ER stress. It was reported that the Akita mouse had a
folding mutation in proinsulin that activated the ER stress
response, resulting in diabetes with loss of beta cell mass
[11]. Our results were in agreement with this report.
Although the number of secretory granules in beta cells of
diabetic rats did not change significantly, the optical density
value of secretory granules were significantly diluted and
the insulin expression was significantly decreased when
compared with that of normal rats, suggesting that imma-
ture insulin or misfolded mutant proinsulin was increased.
In addition, it is thought that chronically elevated levels of
circulating free fatty acids and glucose are putative media-
tors of progressive beta-cell dysfunction and death in
T2DM [31]. Previous studies showed that ER stress
occurred in islets isolated from db/db mice and in pancreas
sections of humans with T2DM [10]. Moreover, a require-
ment for ER stress was previously described for palmitate-
mediated beta cell apoptosis in vitro [9,10]. In the present
study, apart from hyperglycemia and blood lipid disorder
(more details were referred to in our recent report [18]),
we provided evidence of swollen ER and induction of
GRP78, CHOP, JNK and Caspase-12 in diabetic beta cells,
which are predominately regulated under conditions of
severe and prolonged ER stress. Altogether, these results
suggest that misfolded mutant insulin, glucotoxicity andlipotoxicity might induce ER stress, which appears suffi-
cient to cause pancreatic beta-cell dysfunction and death
in type 2 diabetic rats.
A key aspect of our work was the indication that GSPs
(especially at the dose of 500 mg/kg BW) alleviated ER
stress by restoring moderate dilatation of ER and decreas-
ing the expression of GRP78 and the activities of JNK
in diabetic pancreas, which might be one of the mecha-
nisms of its protective action. Indeed, ER stress, protein
misfolding and oxidative stress are intimately interrelated.
On the one hand, cellular reactive oxygen species (ROS)
can increase misfolded protein load and deplete glutathione
in ER. ROS can also cause ER stress through modification
of proteins and lipids that are necessary to maintain ER
homeostasis [32]. On the other hand, it is estimated that
approximately 25% of the ROS generated in a cell might
result from the formation of disulphide bonds in ER during
oxidative protein folding [33]. ER stress also increases leak
of Ca2+ from the ER lumen. Increases in cytosolic Ca2+can
stimulate mitochondrial ROS production through multiple
mechanisms [32]. Subsequently, ROS production can
further amplify ER stress and cause cell death. It is notable
that pancreatic beta cells are considered especially suscep-
tible to attacks by oxidative stress because of the very low
expression of antioxidant enzymes as compared to other
tissues. GSPs were reported to possess a broad spectrum of
pharmacological, medicinal and therapeutic properties
against oxygen free radicals and oxidative stress [34-36]. So
it is still possible that GSPs affect ER stress by preventing
oxidative stress on diabetic pancreas. It remains to be deter-
mined which mechanisms are accountable for the present
observations.
Conclusion
Our results suggested that pancreatic beta-cell dysfunction
and death in T2DM might be due, at least in part, to ER
stress. GSPs brought about its anti-diabetic effect through
normal insulin secretion from the remnant beta cells. GSPs
also alleviated ER stress possibly via restoration of moderate
Ding et al. Nutrition & Metabolism 2013, 10:51 Page 11 of 12
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in diabetic pancreas. This study confirmed and extended
data regarding the anti-diabetic potential of GSPs in vivo
when administered orally to experimentally diabetic rats in-
duced by low dose STZ and a high-carbohydrate/high-fat
diet. However, dissection of the contribution of ER stress to
pathological conditions is quite challenging because of the
lack of specific inhibitors suitable for in vivo administration.
Further in vitro research into the effect of GSPs on pancre-
atic beta-cell failure and ER stress will contribute to our un-
derstanding of the identification of new molecular targets
for protection against diabetes.
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